POST-FEDERAL BUDGET RESPONSE: AUSTRALIAN THYROID FOUNDATION 1 million Australians with undiagnosed thyroid disorders remain at risk of irreparable damage
At the Post Budget Breakfast hosted by AIPS and Medicines Australia, the Honourable Mark Butler MP, Minister for Health and Aged Care spoke about the health priorities of the Federal Budget 2024-25.
As with all Federal Budgets, there is a submission process to lodge requests by January of each year. For the Federal Budget this year, there were 788 submissions lodged, one of which was by the Australian Thyroid Foundation (ATF).
The ATF is a national not-for-profit organisation with charity status aimed at patients and the healthcare community. The ATF’s focus is to support and educate its member base and promote our Good Thyroid Health Messaging throughout the Australian Community.
Australian Thyroid Foundation, CEO Beverley Garside attending the breakfast gave her response to the Federal Budget and the Foundation’s pre-budget submission, which was not granted.
The 3 requests for funding were for,
1. Education tool kit for health care professionals, to use during patient presentations
2. Broad media campaign aimed at young families moving away from standard dietary choices and awareness about the importance of iodine and thyroid health
3. Dietary book for senior Australians with an iodine slant to improve health outcomes, with healthy living choices.
According to the Australia Thyroid Foundation, over 1 million Australians are living with an undiagnosed thyroid disorder. These disorders can affect children, pregnant women, families and the elderly.
-
Clinical research integrates with GP and Pharmacist workflows to supplement practice revenue
Clinical trials are crucial to the development of evidence-based preventative medicines. In addition, participation in clinical trials can also provide patients with opportunities to access new treatments.
“Clinical trials are at the heart of medical advances which look into new ways to treat, prevent, or detect disease. Volunteers often do so to help contribute to advancing scientific research, knowing that they are participating in the hope of helping future generations,” said Charlotte Bradshaw, CEO and Founder to Evrima Technologies.
-
Medical research institutes association responds to draft national research strategy
On 27 August 2025, the Minister for Health, Disability and Ageing announced the release of the draft National Health and Medical Research Strategy (the National Strategy).
Involved in the initial consultation phase, was the Association of Australian Medical Research Institutes (AAMRI), the peak body for medical research institutes across Australia. Member institutes work on a broad spectrum of human health issues such as preventive health, chronic disease, mental health, immunology and Indigenous health. Their research ranges from fundamental biomedical discovery through to clinical research and the translation of research findings.
-
Cardiovascular Disease Risk Guidance and Calculator get long overdue update
Cardiovascular disease (CVD) is responsible for significant morbidity and premature mortality in Australia. Ischaemic heart disease was the leading cause of death in 2020 and cerebrovascular disease was the third most common cause of death.
As the first major update to Australian CVD risk assessment guidelines in over a decade, the 2023 Australian Guideline for assessing and managing cardiovascular disease risk and associated Aus CVD Risk Calculator reflect the latest evidence on assessing, communicating, and managing CVD risk. Developed using Australian-specific data and the latest evidence, it supersedes the 2012 Guidelines for the management of absolute cardiovascular disease risk.
